---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-397996"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2026-09-22T20:30:15+00:00"
generated_at: "2026-09-22T20:31:28.513340+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Alaunos raises $1.12M in registered direct offering of stock and pre-funded warrants

## Summary
- Sold 380,469 common shares at $1.46/share and 386,654 pre-funded warrants at $1.459 each for ~$1.12M gross.
- Net proceeds approximately $915,400.50 after fees; intended for general corporate and working capital purposes.
- Priced at-the-market under Nasdaq rules; Dawson James Securities acted as sole placement agent with 8% cash fee.
- Offering closed September 21, 2026; pre-funded warrants exercisable at $0.001, no expiration, 4.99% beneficial ownership limit.
- Officers and directors entered 15-day lock-up agreements restricting share transfers.

## SEC filing metadata
- accession: 0001193125-26-397996
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2026-09-22T20:30:15+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000119312526397996/0001193125-26-397996-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000119312526397996/tcrt-20260918.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-397996
- JSON: https://secwatch.observer/filing/0001193125-26-397996.json
- Plain text: https://secwatch.observer/filing/0001193125-26-397996.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.